Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Daiichi Sankyo hired Mark Rutstein as head, global oncology clinical development. Previously, he worked at Bristol Myers Squibb as vice president, oncology development. Before that, Rutstein was vice president, global oncology clinical development at Bayer Healthcare.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
